Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Managing shame is important for improving health care
| The first 150 words of the full text of this article appear below. |
In the 1960s the results of a large randomised controlled study by the University Group Diabetes Program showed that tolbutamide, virtually the only blood sugar lowering agent available at the time in pill form, was associated with a significant increase in mortality in patients who developed myocardial infarction. The obvious response from the medical profession should have been gratitude: here was an important way to improve the safety of clinical practice. But in fact the response was doubt, outrage, even legal proceedings against the investigators; the controversy went on for years. Why?
An important clue surfaced at the annual meeting of the American
Diabetes Association soon after the study was published. During the
discussion a practitioner stood up and said he simply could not, and
would not, accept the findings, because admitting to his patients that
he had been using an unsafe treatment would shame him in their eyes.
Other
Read all Rapid Responses